The PANTHER Trial
September 6, 2023 | Marco Valgimigli and C. Michael Gibson discuss the PANTHER trial, which compared P2Y12 inhibitor monotherapy with aspririn monotherapy in patients with coronary artery disease. |
New at TCTMD? Register today!
Enter the email you used to register to reset your password.